Insulin-mimetic species of low molecular weight are speculated to mediate some intracellular insulin actions. These inositol glycans, which are generated upon insulin stimulation from glycosylphosphatidylinositols, might control the activity of a multitude of insulin effector enzymes. Acylated inositol glycans (AIGs) are generated by cleavage of protein-free GPI precursors through the action of GPI-specific phospholipase C (GPI-PLC) and D (GPI-PLD). We synthesized AIGs (IG-1, IG-2, IG-13, IG-14, and IG-15) and then evaluated their insulin-mimicking bioactivities. IG-1 significantly stimulated glycogen synthesis and lipogenesis in 3T3-L1 adipocytes and rat isolated adipocytes dose-dependently. IG-2 significantly stimulated lipogenesis in rat isolated adipocytes dose-dependently. IG-15 also enhanced glycogen synthesis and lipogenesis in 3T3-L1 adipocytes. The administration of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with normal diets. The administration of IG-1 decreased plasma glucose in STZ-diabetic C57B6N mice. The treatment of IG-1 decreased plasma glucose, increased glycogen content in liver and skeletal muscles and improved glucose tolerance in C57B6N mice with high fat-diets and db/db mice. The long-term treatment of IG-1 decreased plasma glucose and reduced food intake and body weight in C57B6N mice with high fat-diets and ob/ob mice. Thus, IG-1 has insulin-mimicking bioactivities and improves glucose tolerance in mice models of diabetes with or without obesity.
References
[1]
Boura-Halfon S, Zick Y (2009) Phosphorylation of IRS proteins, insulin action, and insulin resistance. Am J Physiol Endocrinol Metab 296(4): E581–91. doi: 10.1152/ajpendo.90437.2008
[2]
Larner J, Galasko G, Cheng K, DePaoli-Roach AA, Huang L, et al. (1979) Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 206: 1408–1410. doi: 10.1126/science.228395
[3]
Saltiel AR, Fox JA, Sherline P, Cuatrecasas P (1986) Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of c-AMP phosphodiesterase. Science 233: 967–972. doi: 10.1126/science.3016898
[4]
Jones DR, Varela-Nieto I (1998) The role of glycosylphosphatidylinositol in signal transduction. Int J Biochem Cell Biol 30: 313–326.
[5]
Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, et al. (1999) Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol Genet Metab 68(4): 488–502. doi: 10.1006/mgme.1999.2936
[6]
Kessler A, Muller G, Wied S, Crecelius A, Eckel J (1998) Signaling pathways of an insulin-mimetic phosphoinositolglycan peptide in muscle and adipose tissue. Biochem J 330: 277–286.
[7]
Larner J, Price JD, Heimark D, Smith L, Rule G, et al. (2003) Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity. J Med Chem 46: 3283–3291. doi: 10.1021/jm030071j
[8]
Merida I, Pratt JC, Gaulton GN (1990) Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules. Proc Natl Acad Sci USA 87: 9421–9425. doi: 10.1073/pnas.87.23.9421
[9]
Boudot C, Kadri Z, Petitfrere E, Lambert E, Chretien S, et al. (2002) Phosphatidylinositol 3-kinase regulates glycosylphosphatidylinositol hydrolysis through PLC-γ2 activation in erythropoietin-stimulated cells. Cell Signaling 14: 869–878. doi: 10.1016/s0898-6568(02)00036-0
[10]
Ferguson MAJ (1999) The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. Journal of Cell Science 112(17): 2799–809.
[11]
Jones DR, Avila MA, Sanz C, Varela-Nieto I (1997) Glycosyl-phosphatidylinositol-phospholip？asetype D: A possible candidate for the generation of second messengers. Biochem Biophys Res Commun 233: 432–427. doi: 10.1006/bbrc.1997.6475
[12]
Turner DI, Chakraborty N, d'Alarcao M (2005) A fluorescent inositol phosphate glycan stimulates lipogenesis in rat adipocytes by extracellular activation alone. Bioorg Med Chem Lett 15: 2023–2025. doi: 10.1016/j.bmcl.2005.02.061
[13]
Shashkin PN, Wasner HK, Ortmeyer HK, Hansen BC (2001) Prostaglandylinositol cyclic phosphate (cPIP): a novel second messenger of insulin action. Comparative analysis of two kinds of ‘insulin mediators’. Diab Metab Res Rev 17(4): 273–284. doi: 10.1002/dmrr.218
[14]
Frick W, Bauer A, Bauer J, Wied S, Muller G (1998) Structure-activity relationship of synthetic phosphoinositolglycans mimicking metabolic insulin action. Biochemistry 37(38): 13421–13436. doi: 10.1021/bi9806201
[15]
Jones DR, Varela-Nieto I (1999) Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med 5(8): 505–514.
[16]
Larner J, Price JD, Heimark D, Smith L, Rule G, et al. (2003) Isolation, structure, synthesis, and bioactivity of a novel putative insulin mediator. A galactosamine chiro-inositol pseudo-disaccharide Mn2+ chelate with insulin-like activity. J Med Chem 46(15): 3283–91. doi: 10.1021/jm030071j
[17]
Chakraborty N, d'Alarcao M (2005) An anionic inositol phosphate glycan pseudotetrasaccharide exhibits high insulin-mimetic activity in rat adipocytes. Bioorg Med Chem 13(24): 6732–6741. doi: 10.1016/j.bmc.2005.07.020
[18]
Alvarez JF, Sanchez-Arias JA, Guadano A, Estevez F, Varela I, et al. (1991) Transport in isolated rat hepatocytes of the phospho-oligosaccharide that mimics insulin action. Effects of adrenalectomy and glucocorticoid treatment. Bioch J 274(2): 369–374.
[19]
Larner J, Huang LC (1999) Identification of a novel inositol glycan signaling pathway with significant therapeutic relevance to insulin resistance: an insulin signaling model using both tyrosine kinase and G- proteins. Diabetes Rev 7(3): 217–231.
[20]
Muller G, Jung C, Frick W, Bandlow W, Kramer W (2002) Interaction of phosphatidylinositolglycan(-peptides) with plasma membrane lipid rafts triggers insulin-mimetic signaling in rat adipocytes. Arch Biochem Biophy 408(1): 7–16. doi: 10.1016/s0003-9861(02)00450-2
[21]
Brewis IA, Ferguson MA, Mehlert A, Turner AJ, Hooper NM (1995) Structures of the glycosyl-phosphatidylinositol anchors of porcine and human renal membrane dipeptidase. Comprehensive structural studies on the porcine anchor and interspecies comparison of the glycan core structures. J Biol Chem 270: 22946–22956. doi: 10.1074/jbc.270.39.22946
[22]
Misek DE, Saltiel AR (1992) An inositol phosphate glycan derived from a Trypanosoma brucei glycosyl-phosphatidylinositol mimics some of the metabolic actions of insulin. J Biol Chem 267(23): 16266–73. doi: 10.1210/endo.135.5.7956908
[23]
Muller G, Wied S, Crecelius A, Kessler A, Eckel J (1997) Phosphoinositolglycan-peptides from yeast potently induce metabolic insulin actions in isolated rat adipocytes, cardiomyocytes, and diaphragms. Endocrinology 138(8): 3459–75. doi: 10.1210/endo.138.8.5308
[24]
Muller G, Frick W (1999) Signalling via caveolin: involvement in the cross-talk between phosphoinositolglycans and insulin. Cell Molec Life Sci 56(11–12): 945–970. doi: 10.1007/s000180050485
[25]
Shashkin PN, Shashkina EF, Fernqvist Forbes E, Zhou YP, Grill V, et al. (1997) Insulin mediators in man: Effects of glucose ingestion and insulin resistance. Diabetologia 40(5): 557–563. doi: 10.1007/s001250050715
[26]
Ferguson MAJ (1999) The structure, biosynthesis and functions of glycosylphosphatidylinositol anchors, and the contributions of trypanosome research. J Cell Sci 112(17): 2799–2809.
[27]
Suzuki S, Taneda Y, Hirai S, Satoh Y, Toyota T (1993) Insulin stimulates hydrolysis of plasmanylinositol-glycan and phosphatidylinositol-glycan in rat adipocytes. Insulin-induced generation of inositol glycan, alkylacylglycerol, and diacylglycerol. Diabetes 42(7): 988–994. doi: 10.2337/diab.42.7.988
[28]
Suzuki S, Taneda Y, Hirai S, Yamamoto-Honda R, Toyota T (1992) Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol. Diabetes 41(11): 1373–1379. doi: 10.2337/diabetes.41.11.1373
[29]
Sleight S, Wilson BA, Heimark DB, Larner J (2002) G(q/11) is involved in insulin-stimulated inositol phosphoglycan putative mediator generation in rat liver membranes: co-localization of G(q/11) with the insulin receptor in membrane. doi: 10.1016/s0006-291x(02)00701-5
[30]
Suzuki S, Sugawara K, Satoh Y, Toyota T (1991) Insulin stimulates the generation of two putative insulin mediators, inositol-glycan and diacylglycerol in BC3H-1 myocytes. J Biol Chem 266(13): 8115–21.
[31]
Muller G, Schulz A, Wied S, Frick W (2005) Regulation of lipid raft proteins by glimepiride- and insulin-induced glycosylphosphatidylinositol-specific phospholipase C in rat adipocytes. Biochem Pharmacol 69(5): 761–80. doi: 10.1016/j.bcp.2004.11.014
[32]
Jaworek CH, Calias P, Iacobucci S, d'Alarcao M (1999) Synthesis of an inositol-containing trisaccharide related to insulin signal transduction. Tetrahedron Lett 40(4): 667–670. doi: 10.1016/s0040-4039(98)02530-1
[33]
Hecht ML, Tsai YH, Liu X, Wolfrum C, Seeberger PH (2010) Synthetic inositol phosphoglycans related to GPI lack insulin-mimetic activity. ACS Chem Biol 5(11): 1075–1086. doi: 10.1021/cb1002152
[34]
Roberts WL, Myher JJ, Kuksis A, Low MG, Rosenberry TL (1988) Lipid analysis of the glycoinositol phospholipid membrane anchor of human erythrocyte acetylcholinesterase. Palmitoylation of inositol results in resistance to phosphatidylinositol-specific phospholipase C. J Biol Chem 263: 18766–18775.
[35]
Schofield JN, Rademacher TW (2000) Structure and expression of the human glycosylphosphatidylinositol phospholipase D1 (GPLD1) gene. Biochim Biophys Acta 1494(1–2): 189–194. doi: 10.1016/s0167-4781(00)00194-9
[36]
Rhode H, Lopatta E, Schulze M, Pascual C, Schulze HP, et al. (1999) Glycosylphosphatidylinositol-specific phospholipase D in blood serum: is the liver the only source of the enzyme? Clin Chim Acta 281(1–2): 127–145. doi: 10.1016/s0009-8981(98)00218-6
[37]
Deeg MA, Verchere CB (1997) Regulation of glycosylphosphatidylinositol-specific phospholipase D secretion from beta TC3 cells. Endocrinology 138(2): 819–826. doi: 10.1210/en.138.2.819
[38]
Metz CN, Zhang YY, Guo Y, Tsang TC, Kochan JP, et al. (1991) Production of the glycosylphosphatidylinositol-specific phospholipase D by the islets of Langerhans. J Biol Chem 266(27): 17733–17736.
[39]
Bowen RF, Raikwar NS, Olson LK, Deeg MA (2001) Glucose and insulin regulate glycosylphosphatidylinositol-specific phospholipase D expression in islet beta cells. Metabolism 50(12): 1489–1492. doi: 10.1053/meta.2001.28087
[40]
Schofield JN, Stephens JW, Hurel SJ, Bell KM, deSouza JB, et al. (2002) Insulin reduces serum glycosylphosphatidylinositol phospholipase D levels in human type I diabetic patients and streptozotocin diabetic rats. Mol Genet Metab 75(2): 154–161. doi: 10.1006/mgme.2001.3287
[41]
Deeg MA, Bowen RF, Williams MD, Olson LK, Kirk EA, et al. (2001) Increased expression of GPI-specific phospholipase D in mouse models of type 1 diabetes. Am J Physiol Endocrinol Metab 281(1): E147–54.
[42]
Ruiz-Albusac JM, Velázquez E, Iglesias J, Jimenez E, Blázquez E (1997) Insulin promotes the hydrolysis of a glycosyl phosphatidylinositol in cultured rat astroglial cells. J Neurochem 68(1): 10–19. doi: 10.1046/j.1471-4159.1997.68010010.x
[43]
Kurtz TA, Fineberg NS, Considine RV, Deeg MA (2004) Insulin resistance is associated with increased serum levels of glycosylphosphatidylinositol-specific phospholipase D. Metabolism 53(2): 138–139. doi: 10.1016/j.metabol.2003.09.004
[44]
Gray DL, O'Brien KD, D'Alessio DA, Brehm BJ, Deeg MA (2008) Plasma glycosylphosphatidylinositol-specific phospholipase D predicts the change in insulin sensitivity in response to a low-fat but not a low-carbohydrate diet in obese women. Metabolism 57(4): 473–478. doi: 10.1016/j.metabol.2007.11.007
[45]
Deborde S, Schofield JN, Rademacher TW (2003) Placental GPI-PLD is of maternal origin and its GPI substrate is absent from placentae of pregnancies associated with pre-eclampsia. J Reprod Immunol 59(2): 277–294. doi: 10.1016/s0165-0378(03)00054-8
[46]
Pa？eda C, Villar AV, Alonso A, Go？i FM, Varela F, et al. (2001) Purification and characterization of insulin-mimetic inositol phosphoglycan-like molecules from grass pea (Lathyrus sativus) seeds. Mol Med 7(7): 454–460.
[47]
Deeg MA (1994) GPI-specific phospholipase D as an apolipoprotein. Braz J Med Biol Res 27(2): 375–381.
[48]
Deeg MA, Bierman EL, Cheung MC (2001) GPI-specific phospholipase D associates with an apoA-I- and apoA-IV-containing complex. J Lipid Res 42(3): 442–451.
[49]
Raikwar NS, Cho WK, Bowen RF, Deeg MA (2006) Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism. Am J Physiol Endocrinol Metab 290(3): E463–470. doi: 10.1152/ajpendo.00593.2004
[50]
Deeg MA, Raikwar NS, Johnson C, Williams CD (2007) Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D. Transl Res 150(3): 153–157. doi: 10.1016/j.trsl.2007.03.008
[51]
Chalasani N, Vuppalanchi R, Raikwar NS, Deeg MA (2006) Glycosylphosphatidylinositol-specific phospholipase d in nonalcoholic Fatty liver disease: a preliminary study. J Clin Endocrinol Metab 91(6): 2279–2285. doi: 10.1210/jc.2006-0075
[52]
Armesto J, Hannappel E, Leopold K, Fischer W, Bublitz R, et al. (1996) Microheterogeneity of the hydrophobic and hydrophilic part of the glycosylphosphatidylinositol anchor of alkaline phosphatase from calf intestine. Eur J Biochem 238(1): 259–69. doi: 10.1111/j.1432-1033.1996.0259q.x
[53]
Yamada T, Oka Y, Katagiri H (2008) Inter-organ metabolic communication involved in energy homeostasis: Potential therapeutic targets for obesity and metabolic syndrome. Pharmacol Ther 117: 188–198. doi: 10.1016/j.pharmthera.2007.09.006
